Minipress GITS
Executive Summary
Pfizer files NDA for the controlled-release form of prazosin in Alza's GITS technology. The new formulation requires a single daily dose. Pfizer plans to file an electronic NDA for the product, which will be the firm's second electronic submission. The first was for Procardia GITS, filed in January.